Immune-related Adverse Events and Survival in Solid Tumors Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

Immune-related Adverse Events and Survival in Solid Tumors Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis

Published:2019-09-30 Issue:1 Volume:43 Page:1-7
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Petrelli Fausto,Grizzi Giulia,Ghidini Michele,Ghidini Antonio,Ratti Margherita,Panni Stefano,Cabiddu Mary,Ghilardi Mara,Borgonovo Karen,Parati Maria C.,Tomasello Gianluca,Barni Sandro,Berruti Alfredo,Brighenti Matteo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference60 articles.

1. The blockade of immune checkpoints in cancer immunotherapy;Pardoll;Nat Rev Cancer,2012

2. PD-1 and its ligands in tolerance and immunity;Keir;Annu Rev Immunol,2008

3. The mechanism of anti-CTLA-4 activity and the negative regulation of T-cell activation;Wolchok;Oncologist,2008

4. Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial;Rittmeyer;Lancet,2017

5. Patient performance status and cancer immunotherapy efficacy: a meta-analysis;Bersanelli;Med Oncol,2018

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple immune-related adverse events secondary to checkpoint inhibitor therapy in patients with advanced cancer: association with treatment effectiveness;Frontiers in Oncology;2024-06-26

2. Safety and efficacy of restarting immune checkpoint inhibitors in non-small cell lung cancer patients following immune-related adverse events: a systematic review and meta-analysis;Clinical and Translational Oncology;2024-06-26

3. Rapid onset pembrolizumab-induced inflammatory arthritis diagnosed using musculoskeletal ultrasound;BMJ Case Reports;2024-04

5. Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis;Nature Communications;2024-03-26